Alcon has officially completed the deactivation of two algorithms used for CustomCornea treatment of myopia with or without astigmatism, the U.S. Food and Drug Administration announced. The algorithms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback